Re: you won’t see anyone buying this
in response to
by
posted on
Dec 06, 2023 12:41PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
"I don't see pockets being lined just the superb management skills that Toinvest and others have been pointing out for a number of years"
Over 30% dilution in 2 years looks like superb management skills at lining pockets to me. Not sure who's pockets but there stuffed to the point they can't get their hands in them.